Recruiting
Phase 3

Effect of Reslizumab in Chronic Rhinosinusitis

Sponsor:

Joshua S. Jacobs

Code:

NCT02799446

Conditions

Sinusitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Reslizumab

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information